🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
To determine the effect of steady-state tipranavir 500 mg/ritonavir 200 mg ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT02229760
Treatments Being Tested
The aim of this trial is to evaluate the safety and virological and immunol...
Status
Completed
Location
Boehringer Ingelheim Investigational site 9
Start Date
2009-09
Trial ID
NCT00976950
Treatments Being Tested
This study was designed to provide early access to and evaluate the safety ...
Status
Approved For Marketing
Location
1182.70.127 Health Services Center, Inc.
Start Date
2004-12
Trial ID
NCT00097799
Treatments Being Tested
This study evaluated the safety and tolerability of tipranavir to improve t...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-05
Trial ID
NCT00144287
Treatments Being Tested
Objectives of the study were to evaluate the efficacy and safety of two dif...
Status
Terminated
Location
Multiple Locations
Start Date
1999-12
Trial ID
NCT02239835
A dose defining study of the protease inhibitor tipranavir (TPV), boosted w...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2002-03-29
Trial ID
NCT00275444
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
1182.14.00001 Boehringer Ingelheim Investigational Site
Start Date
2003-11
Trial ID
NCT00076999
Treatments Being Tested
The purpose of this research study is to determine which of three different...
Status
Completed
Location
Phoenix Body Positive
Start Date
2002-04
Trial ID
NCT00034866
Treatments Being Tested
The purpose of this study is to identify an optimal dose combination(s) of ...
Status
Completed
Location
1182.107.49002 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00530920
Treatments Being Tested